These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25330768)

  • 1. Enhanced shRNA delivery and ABCG2 silencing by charge-reversible layered nanocarriers.
    Chen Z; Zhang L; He Y; Shen Y; Li Y
    Small; 2015 Feb; 11(8):952-62. PubMed ID: 25330768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced chemotherapy efficacy by co-delivery of shABCG2 and doxorubicin with a pH-responsive charge-reversible layered graphene oxide nanocomplex.
    He Y; Zhang L; Chen Z; Liang Y; Zhang Y; Bai Y; Zhang J; Li Y
    J Mater Chem B; 2015 Aug; 3(31):6462-6472. PubMed ID: 32262554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
    Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy.
    Javan B; Atyabi F; Shahbazi M
    Life Sci; 2018 Jun; 202():140-151. PubMed ID: 29656061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
    Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
    Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD133(+) laryngeal carcinoma cells with chemotherapeutic drugs and siRNA against ABCG2 mediated by thermo/pH-sensitive mesoporous silica nanoparticles.
    Qi X; Yu D; Jia B; Jin C; Liu X; Zhao X; Zhang G
    Tumour Biol; 2016 Feb; 37(2):2209-17. PubMed ID: 26353857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
    Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
    Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute in vivo toxicity mitigation of PEI-coated maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery.
    Israel LL; Lellouche E; Ostrovsky S; Yarmiayev V; Bechor M; Michaeli S; Lellouche JP
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15240-55. PubMed ID: 26120905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
    Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
    Xie N; Mou L; Yuan J; Liu W; Deng T; Li Z; Jing Y; Hu Z
    PLoS One; 2014; 9(7):e103463. PubMed ID: 25076217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of Cellulose-Nanocrystal-Based Folate Targeted Nanomedicine via Layer-by-Layer Assembly with Lysosomal pH-Controlled Drug Release into the Nucleus.
    Li N; Zhang H; Xiao Y; Huang Y; Xu M; You D; Lu W; Yu J
    Biomacromolecules; 2019 Feb; 20(2):937-948. PubMed ID: 30621397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable Thermo-Sensitive Chitosan Hydrogel Containing CPT-11-Loaded EGFR-Targeted Graphene Oxide and SLP2 shRNA for Localized Drug/Gene Delivery in Glioblastoma Therapy.
    Lu YJ; Lan YH; Chuang CC; Lu WT; Chan LY; Hsu PW; Chen JP
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.
    Alameh M; Dejesus D; Jean M; Darras V; Thibault M; Lavertu M; Buschmann MD; Merzouki A
    Int J Nanomedicine; 2012; 7():1399-414. PubMed ID: 22457597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.